Cleared Special

K201244 - Concorde Models Concorde US and Concorde ST Soft Tissue Biopsy Devices (FDA 510(k) Clearance)

Aug 2020
Decision
91d
Days
Class 2
Risk

K201244 is an FDA 510(k) clearance for the Concorde Models Concorde US and Concorde ST Soft Tissue Biopsy Devices. This device is classified as a Instrument, Biopsy (Class II - Special Controls, product code KNW).

Submitted by Transmed7, LLC (Portola Valley, US). The FDA issued a Cleared decision on August 7, 2020, 91 days after receiving the submission on May 8, 2020.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1075.

Submission Details

510(k) Number K201244 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2020
Decision Date August 07, 2020
Days to Decision 91 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Statement

Device Classification

Product Code KNW - Instrument, Biopsy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1075

Similar Devices - KNW Instrument, Biopsy

All 15
Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module
K260365 · Devicor Medical Products, Inc. · Mar 2026
ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit)
K252795 · Argon Medical Devices, Inc. · Feb 2026
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K252681 · Bard Peripheral Vascular, Inc. · Dec 2025
Resitu Slider 09 (RESL09)
K252183 · Resitu Medical AB · Sep 2025
Forcyte Autograft Harvest Kit
K243407 · Forcyte Medical, LLC · Jul 2025
Disposable Biopsy Needle
K244018 · Zhejiang Curaway Medical Technology Co., Ltd. · Jul 2025